The Use of Extracorporeal Membrane Oxygenation for COVID-19 : Lessons Learned - 19/04/23

Doi : 10.1016/j.ccm.2022.11.016

Madhavi Parekh, MD ^a,^⁎ , Darryl Abrams, MD ^a, Cara Agerstrand, MD ^a, Jenelle Badulak, MD ^b, Amy Dzierba, PharmD ^c, Peta M.A. Alexander, MBBS ^d,^e, Susanna Price, MBBS ^f,^g, Eddy Fan, MD, PhD ^h, Dana Mullin, MS, CCP, LP ⁱ, Rodrigo Diaz, MD ^j, Carol Hodgson, PhD ^k,^l,^{^{1
Cosenior authors.}}, Daniel Brodie, MD ^a,^{^{1
Cosenior authors.}}
^a Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, 622 West 168th Street, PH8-101, New York, NY 10023, USA
^b Department of Emergency Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, 4408 S Holly Street, Seattle, WA 98118, USA
^c Department of Pharmacy, NewYork-Presbyterian Hospital, 622 West 168th Street, VC Basement (pharmacy), New York, NY 10032, USA
^d Department of Cardiology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA
^e Department of Pediatrics, Harvard Medical School, Boston, MA, USA
^f Royal Brompton & Harefield Hospitals, Guys and St Thomas’s NHS Foundation Trust, Sydney Street, London, SW3 6NP, UK
^g National Heart and Lung Institute, Imperial College, London, UK
^h Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto General Hospital, 585 University Avenue, 9-MaRS-9013, Toronto, Ontario, M5G 2N2, Canada
ⁱ Department of Clinical Perfusion and Anesthesia Support Services, NewYork-Presbyterian Hospital, New York, NY, USA
^j Clinica Las Condes, Clinica Red Salud Santiago CCHC, Camino El Cajon 18274, casa 5, Lo Barnechea, Santiago, 7710260, Chile
^k Department of Epidemiology and Preventive Medicine, Australian and New Zealand Intensive Care-Research Centre, Monash University, 3/553 Street Kilda Road, Melbourne 3004, Australia
^l Department of Intensive Care, Alfred Health, Melbourne, Australia

^∗Corresponding author. 622 West 168th Street, PH8-101, New York, NY 10023.622 West 168th Street, PH8-101New YorkNY10023

connectez-vous ou créez un compte

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

The coronavirus disease 2019 (COVID-19) pandemic has seen an increase in global cases of severe acute respiratory distress syndrome (ARDS), with a concomitant increased demand for extracorporeal membrane oxygenation (ECMO). Outcomes of patients with severe ARDS due to COVID-19 infection receiving ECMO support are evolving. The need for surge capacity, practical and ethical limitations on implementing ECMO, and the prolonged duration of ECMO support in patients with COVID-19-related ARDS has revealed limitations in organization and resource utilization. Coordination of efforts at multiple levels, from research to implementation, resulted in numerous innovations in the delivery of ECMO.

Le texte complet de cet article est disponible en PDF.

Keywords : ECMO, Acute respiratory distress syndrome, ARDS, COVID-19, Respiratory failure

Plan

Export

Vol 44 - N° 2

P. 335-346 - juin 2023 Retour au numéro

Article précédent

Lessons Learned in Mechanical Ventilation/Oxygen Support in Coronavirus Disease 2019
Laura Dragoi, Matthew T. Siuba, Eddy Fan

| Article suivant

Lung Transplantation in Coronavirus-19 Patients : What We Have Learned So Far
Emily Cerier, Kalvin Lung, Chitaru Kurihara, Ankit Bharat

Bienvenue sur EM-consulte, la référence des professionnels de santé.

connectez-vous ou créez un compte

The Use of Extracorporeal Membrane Oxygenation for COVID-19 : Lessons Learned - 19/04/23

Résumé

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL